Publications To Date


    Filter Publications

    PAGE 64 OF 87 | DISPLAYING 946 - 960 OF 1293 RESULTS

    Baillie R. et al., Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma, [Epub ahead of print]., J. Clin Pathol., Apr 19, 2016

    Hesbacher S. et al., RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells., [Epub ahead of print]., Oncotarget, Apr 18, 2016

    Nowakowski R. et al., ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphom, [Epub ahead of print]., Future Oncol., Apr 18, 2016

    Gonzalez-Rivera M. et al., Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial., [Epub ahead of print]., Breast Can Res. and Treat, Apr 15, 2016

    Norton N. et al., Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors., [Epub ahead of print]., PLoS ONE, Apr 14, 2016

    Castro N. et al., Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies., [Epub ahead of print]., PLoS ONE, Apr 14, 2016

    Hu S. et al., Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes., [Epub ahead of print]., Sci. Reports, Apr 12, 2016

    Townsend E.C. et al., The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice., [Epub ahead of print]., Cancer Cell, Apr 11, 2016

    Romeo C. et al., HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Apr 06, 2016

    Parasramka M. et al., Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death., [Epub ahead of print]., European Urology Focus, Apr 02, 2016

    Spears M. et al., A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial., [Epub ahead of print]., Oncotarget, Apr 01, 2016

    Thompson E.M. et al., Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis., [Epub ahead of print]., The Lancet Oncology, Apr 01, 2016

    Wuerstlein R. et al., The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer., [Epub ahead of print]., Curr. Med. Res. Opin., Mar 30, 2016

    Griffiths O.L. et al., A genomic case study of mixed fibrolamellar hepatocellular carcinoma., [Epub ahead of print]., Annals Oncol., Mar 30, 2016

    Shen F. et al., Novel Small-molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Mar 21, 2016